Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Diana Jacobs
Repetitive CAG or glutamine expression along the Huntington gene’s coding region results in the progressive neurodegenerative disorder known as Huntington’s disease (HD). Certain abnormalities in movement, emotional disturbances, dementia, and cognitive impairments are the effects of this disease. To this date, there could be no legitimate remedy for this uncommon and deadly neurological condition yet there have been sure headways in the field of hereditary creature model examination studies to explain the comprehension of the pathogenesis of this condition. Currently, HD follows a specific therapeutic approach that only treats symptoms and does not address the disease’s underlying cause. Stem cell therapy has the potential to be a game-changer in the search for a cure. The pathogenesis, efficacy, and clinical viability of the therapeutic application of stem cell transplantation in Huntington’s disease have all been discussed in this review. A brief list and analysis of the applications of this revolutionary therapy on genetically modified animal models has been provided.